Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat

Psychopharmacology

Volumn 167, Issue 2, 2003, Pages 115-122

  Hartfield, Abegale W ^a   Moore, Nicholas A ^b   Clifton, Peter G ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Antipsychotic; Clozapine; Haloperidol; Hyperphagia; Microstructure; Olanzapine; Rat

Indexed keywords

CLOZAPINE; HALOPERIDOL; INTRALIPID; LIPID EMULSION; OLANZAPINE;

ANALYSIS OF VARIANCE; ANIMAL MODEL; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; DOSE RESPONSE; DRINKING; FAT INTAKE; FOOD INTAKE; HYPERPHAGIA; INGESTION; LICKING; MALE; MOTOR DYSFUNCTION; NEGATIVE FEEDBACK; NONHUMAN; OBESITY; PALATABILITY; PRIORITY JOURNAL; RAT; SATIETY; WEIGHT GAIN;

EID: 0038693732     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1368-8     Document Type: Article

References (33)

1. Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ (1999) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156:1686-1696
2. Asin KE, Davis JD, Bednarz L (1992) Differential effects of the serotonergic and catecholaminergic drugs on ingestive behavior. Psychopharmacology 109:415-421
3. Baptista T (1999) Body weight gain induced by antipsychotic drugs: mechanisms and management. Acta Psychiatr Scand 100:3-16
4. 2 receptors involved? Pharmacol Biochem Behav 27:399-405
5. Baptista T, Mata A, Teneud L, De Quijada M, Han HW, Hernandez L (1993) Effects of long-term administration of clozapine on body weight and food intake in rats. Pharmacol Biochem Behav 45:51-54
6. Basson BR, Kinon BJ, Taylor CC, Szymanski KA, Gilmore JA, Tollefson GD (2001) Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol or risperidone. J Clin Psychiatry 62:231-238
7. Beasley CM, Tollefson G, Tran P, Satterlee W, Sanger T, Hamilton S (1996) Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology 14:111-123
8. Benvenga MJ, Leander JD (1997) Increased food consumption by clozapine, but not by olanzapine, in satiated rats. Drug Dev Res 41:48-50
9. Brown S, Birtwistle J, Roe L, Thompson C (1999) The unhealthy lifestyle of people with schizophrenia. Psychol Med 29:697-701
10. 2C receptor agonist, and d-fenfluramine on feeding patterns in the rat. Psychopharmacology 152:256-267
11. Davis JD (1973) The effectiveness of some sugars in stimulating licking behaviour in the rat. Physiol Behav 11:39-45
12. Davis JD, Perez MC (1993) Food deprivation-and palatability-induced microstructural changes in ingestive behavior. Am J Physiol 264 (Reg Int Comp Physiol 33):R97-R103
13. Davis JD, Smith GP (1992) Analysis of the microstructure of the rhythmic tongue movements of rats ingesting maltose and sucrose solutions. Behav Neurosci 106:217-228
14. Dourish CT (1995) Multiple serotonin receptors: opportunities for new treatments for obesity? Obesity Res 3:449S-462S
15. Esel E, Basturk M, Saffet Gonul A, Kula M, Tayfun Turan M, Yabanoglu I, Sofuoglu S (2001) Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients. Psychoneuroendocrinology 26:641-647
16. Garattini S, Mennini T, Samanin R (1989) Reduction of food intake by manipulation of central serotonin: current experimental results. Br J Psychiatry 155:41-51
17. Geary N, Smith GP (1985) Pimozide decreases the positive reinforcing effect of sham fed sucrose in the rat. Pharmacol Biochem Behav 22:787-790
18. Goodall E, Oxtoby C, Richards R, Watkinson G, Silverstone T (1988) A clinical trial of the efficacy and acceptability of d-fenfluramine in the treatment of neuroleptic-induced obesity. Br J Psychiatry 153:208-213
19. Howell DC (1997) Statistical methods for psychology, 4th edn. Duxbury Press, London
20. 3H-raclopride reveals much higher occupancy than EEDQ. Neuropsychopharmacology 23:595-598
21. Kraus T, Haack M, Schuld A, Hinze-Selch D, Kuhn M, Uhr M, Pollmacher T (1999) Body weight regulation and leptin plasma levels during treatment with antipsychotic drugs. Am J Psychiatry 156:312-314
22. 3 agonists on food and water intake and urine flow in Wistar rats. Brain Res 793:279-288
23. Lee MD, Clifton PG (1992) Partial reversal of fluoxetine anorexia by the 5-HT antagonist metergoline. Psychopharmacology 107:359-364
24. Lee MD, Clifton PG (2002) Meal patterns of free feeding rats treated with clozapine, olanzapine or haloperidol. Pharmacol Biochem Behav 71:147-154
25. Moore NA, Bymaster FP (1999) Neuropharmacological profiles of novel antipsychotic agents. In: Palomo T, Beninger RJ, Archer T (eds) Interactive monoaminergic disorders, strategies for studying brain disorders 4. Editorial Sintesis, Madrid
26. Remington G, Kapur S (2000) Atypical antipsychotics: are some more atypical than others? Psychopharmacology 148:3-15
27. 1-histamine receptor agonist betahistine on drinking and eating behaviour in pygmy goats. Physiol Behav 66:517-521
28. Spector AC, Klumpp PA, Kaplan JM (1998) Analytical issues in the evaluation of food deprivation and sucrose concentration effects of the microstructure of licking behaviour in the rat. Behav Neurosci 112:678-694
29. Stanton JM (1995) Weight gain associated with neuroleptic medication: a review. Schizophr Bull 21:463-472
30. 2C receptors. Neuropharmacology 41:200-209
31. Ward BO, Somerville EM, Clifton PG (2000) Intraccumbens baclofen selectively enhances feeding behaviour in the rat. Physiol Behav 68:463-468
32. Warwick ZS, Schiffman SS (1992) Role of dietary fat in calorie intake and weight gain. Neurosci Biobehav Rev 16:585-596
33. Wirshing DA, Wirshing WC, Kysar L, Berisford MA, Goldstein D, Pashdag J, Mintz J, Marder SR (1999) Novel antipsychotics: comparison of weight gain liabilities. J Clin Psychol 60:358-363